WELLS FARGO & COMPANY/MN
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$922,768
+$580,880 QoQ
Shares Held
61,765
+164.3% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 172 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,022 across 417 Biotechnology names. CRVS ranks #140 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CRVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $922,768 | 61,765 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $341,888 | 23,369 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $482,196 | 62,623 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $268,230 | 36,395 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $108,280 | 27,070 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,360 | 2,000 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $904 | 169 | Shares | Defined | 2025-02-13 | |
| 2024-03-31 | $471 | 265 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $457 | 260 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $360 | 247 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $567 | 248 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $216 | 238 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $199 | 235 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $187 | 229 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $215 | 218 | Shares | Defined | 2022-08-12 | |
| 2021-09-30 | $880 | 182 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $440 | 165 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $505 | 164 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $370 | 104 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $392 | 98 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $214 | 79 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $166 | 79 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||